Afuco™ Anti-Human SIGLEC15 ADCC Therapeutic Antibody (AB-25E9), ADCC Enhanced
Anti-SIGLEC15 ADCC Enhanced Antibody (AB-25E9) is an ADCC enhanced antibody produced by our Afuco™ platform. AB-25E9 is a humanized IgG2 that inhibits the function of Siglec-15 and has tremendous potential as a novel antiresorptive for the treatment of patients with acute bone loss.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-546CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | SIGLEC15 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |